Journal article

CRISPR- Cas systems for infectious disease and cancer biomarker detection

ASAditi Suman
Year2026
Volume8
Issue3
Pages85-92

Abstract

Medical devices are essential components of contemporary health systems, but their safety, performance and availability depend on an effective regulatory system operating throughout the product life cycle. Regulatory approaches differ across jurisdictions according to national legislation, institutional capacity, risk classification, conformity assessment arrangements and post-market surveillance mechanisms. This review compares the current regulatory frameworks for medical devices in the European Union (EU) and India and examines their possible relevance to Tanzania. The analysis uses current legislation, regulatory guidance and official information from the European Commission, the Central Drugs Standard Control Organization (CDSCO), the Tanzania Medicines and Medical Devices Authority (TMDA) and the World Health Organization (WHO). The EU framework is based principally on Regulation (EU) 2017/745 on medical devices (MDR) and Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR), while India regulates medical devices under the Drugs and Cosmetics Act, 1940 and Medical Devices Rules, 2017. Tanzania regulates medical devices through TMDA under the Tanzania Medicines and Medical Devices Act, Cap. 219 and associated regulations and guidelines. All three systems use risk-based concepts, although the classes, regulatory pathways and conformity assessment mechanisms are not identical. Tanzania already has a structured framework, including risk classification, registration or notification, quality-system requirements, post-market surveillance and online regulatory processes. The principal opportunity is therefore not to replicate another jurisdiction, but to strengthen implementation through risk-proportionate review, regulatory reliance, technical capacity, digital information systems, post-market surveillance and stakeholder coordination. The comparison provides a basis for practical, context-sensitive recommendations for strengthening Tanzania’s medical device regulatory system.

Cite this article

Citation data